Vaccines | Notable Papers Published in 2024 in the “Vaccination Against Cancer and Chronic Diseases” Section
1. “New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3”
by Ioannis-Alexios Koumprentziotis, Charalampos Theocharopoulos, Dimitra Foteinou, Erasmia Angeli, Amalia Anastasopoulou, Helen Gogas and Dimitrios C. Ziogas
Vaccines 2024, 12(1), 54; https://doi.org/10.3390/vaccines12010054
Full text available online: https://www.mdpi.com/2076-393X/12/1/54
2. “Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer”
by Dechen Wangmo, Travis J. Gates, Xianda Zhao, Ruping Sun and Subbaya Subramanian
Vaccines 2024, 12(1), 63; https://doi.org/10.3390/vaccines12010063
Full text available online: https://www.mdpi.com/2076-393X/12/1/63
3. “Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art”
by Hamid Heydari Sheikhhossein, Francesca Iommelli, Natalia Di Pietro, Maria Cristina Curia, Adriano Piattelli, Rosanna Palumbo, Giovanni N. Roviello and Viviana De Rosa
Vaccines 2024, 12(5), 519; https://doi.org/10.3390/vaccines12050519
Full text available online: https://www.mdpi.com/2076-393X/12/5/519
4. “Dendritic Cells as a Therapeutic Strategy in Acute Myeloid Leukemia: Vaccines”
by Francisca Palomares, Alejandra Pina, Hala Dakhaoui, Camila Leiva-Castro, Ana M. Munera-Rodriguez, Marta Cejudo-Guillen, Beatriz Granados, Gonzalo Alba, Consuelo Santa-Maria, Francisco Sobrino et al.
Vaccines 2024, 12(2), 165; https://doi.org/10.3390/vaccines12020165
Full text available online: https://www.mdpi.com/2076-393X/12/2/165
5. “Synergistic Effects of Metal–Organic Nanoplatform and Guanine Quadruplex-Based CpG Oligodeoxynucleotides in Therapeutic Cancer Vaccines with Different Tumor Antigens”
by Xia Li, Mitsuhiro Ebara, Naoto Shirahata, Tomohiko Yamazaki and Nobutaka Hanagata
Vaccines 2024, 12(6), 649; https://doi.org/10.3390/vaccines12060649
Full text available online: https://www.mdpi.com/2076-393X/12/6/649
6. “Characterization of the Anti-Viral and Vaccine-Specific CD8+ T Cell Composition upon Treatment with the Cancer Vaccine VSV-GP”
by Tamara Hofer, Lisa Pipperger, Sarah Danklmaier, Krishna Das and Guido Wollmann
Vaccines 2024, 12(8), 867; https://doi.org/10.3390/vaccines12080867
Full text available online: https://www.mdpi.com/2076-393X/12/8/867
7. “Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth”
by Martin R. Ramos-Gonzalez, Mohammad Tarique, Lalit Batra, Feyza Arguc, Rodolfo Garza-Morales, Haval Shirwan, Esma S. Yolcu and Jorge G. Gomez-Gutierrez
Vaccines 2024, 12(3), 340; https://doi.org/10.3390/vaccines12030340
Full text available online: https://www.mdpi.com/2076-393X/12/3/340
8. “TLR7 Agonist-Loaded Gadolinium Oxide Nanotubes Promote Anti-Tumor Immunity by Activation of Innate and Adaptive Immune Responses”
by Xiupeng Wang, Motohiro Hirose and Xia Li
Vaccines 2024, 12(4), 373; https://doi.org/10.3390/vaccines12040373
Full text available online: https://www.mdpi.com/2076-393X/12/4/373
9. “Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC)”
by Caterina Lapenta, Stefano Maria Santini, Celeste Antonacci, Simona Donati, Serena Cecchetti, Patrizia Frittelli, Piera Catalano, Francesca Urbani, Iole Macchia, Massimo Spada et al.
Vaccines 2024, 12(9), 1058; https://doi.org/10.3390/vaccines12091058
Full text available online: https://www.mdpi.com/2076-393X/12/9/1058
10. “GSK-3β in Dendritic Cells Exerts Opposite Functions in Regulating Cross-Priming and Memory CD8 T Cell Responses Independent of β-Catenin”
by Chunmei Fu, Jie Wang, Tianle Ma, Congcong Yin, Li Zhou, Björn E. Clausen, Qing-Sheng Mi and Aimin Jiang
Vaccines 2024, 12(9), 1037; https://doi.org/10.3390/vaccines12091037
Full text available online: https://www.mdpi.com/2076-393X/12/9/1037